Navigation Links
David Passov Named to PharmaVOICE 100
Date:8/3/2011

SAN FRANCISCO, Aug. 3, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in Russia and Eastern Europe to the pharmaceutical and biotechnology industry, is pleased to announce that President and CEO David Passov has been named one of the 100 most inspiring people in the life-sciences industry by PharmaVOICE magazine.

(Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)

According to the editors at PharmaVOICE, "Recognizing the importance of emerging nations in improving recruitment for clinical trials, David Passov has been educating the industry about the huge potential open to it within Russia, Ukraine, Belarus and the Baltics. Mr. Passov works hard to dispel any rumors or myths about these markets, noting that the clear advantage of conducting clinical trials in markets such as Russia is that companies can enroll patients three to 20 times faster than in the United States and Western Europe."  In a recent interview with NPR, Mr. Passov "helped convey how ongoing drug research in Russia benefits the general population by providing quicker access to advanced healthcare that may otherwise not be available for years or ever at all."

"I am honored to receive this distinguished recognition from PharmaVOICE. It is a satisfying affirmation of the work we are doing in conjunction with the biopharmaceutical industry in the region, and ultimately, the positive impact we are having on bringing more advance healthcare to the people of Russia and Eastern Europe," says Mr. Passov.

Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers and represent a broad cross section of industry sectors. Those chosen contribute to the growth and well-being of their individual companies, their communities and varied industry associations.

About ClinStar, LLC

ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics, with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of nearly 300 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at www.clinstar.com.


'/>"/>
SOURCE ClinStar, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Proves McDavid Ankle Braces Significantly Prevent Injuries
2. DePuy ASR Hip Resurfacing System Failure Leads to Lawsuit, According to the Law Offices of John David Hart
3. Vicor Technologies CEO David H. Fater to Present Live, Online at RetailInvestorConferences.com
4. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
5. Medco Chairman and CEO David Snow Addresses Shareholders, Highlighting Another Year of Growth, Innovation and Substantial Client Savings - With More to Come
6. Recalled DePuy ASR Hip Implant Lawsuits Filed By John David Hart
7. David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly
8. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer
9. Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment
10. Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman
11. St. Davids HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. Davids North Austin Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):